In collaboration with the University of Colorado, etectRx has made significant strides in advancing medication adherence monitoring through the QUANTI-TAF study (NCT04065347). Recently published in Clinical Infectious Diseases1 and the British Journal of Clinical Pharmacology2, the QUANTI-TAF study focused on antiretroviral therapy (ART) adherence among persons with HIV (PWH) receiving daily oral tenofovir alafenamide/emtricitabine (TAF/FTC)-based ART for at least…
Case 4: Streamlining Care and Reducing Clinical Risk
Authored by Leah Klusch, RN, BSN, FACHCA, Executive Director, The Alliance Training Center
Managing continence care in long-term care settings is a complex challenge. Incontinence treatment is among the highest expenses for providers, largely due to staffing shortages and the various regulatory and psychosocial factors involved. Addressing this…
EdenHill Communities Partners with etectRx for Innovative Incontinence Care Solution
FOR IMMEDIATE RELEASE
GAINESVILLE, Florida (February 5, 2025) – etectRx™, Inc. (etectRx™), a leading digital health sensor company, is excited to announce its partnership with EdenHill Communities, marking the first eBrief™ Early Adopter Program (EAP) partnership in the State of Texas. This collaboration aims to…
Case 3: Boosting Your Bottom Line
As we enter a new year, senior living services face an increasingly complex landscape of reimbursement models and regulatory requirements. Terms like ACOs, MCOs, PDPM, and VBC can be overwhelming. With a growing array of payer options, senior living executives must navigate these complexities while ensuring the well-being of residents.…